Cliff Asness's TEVA Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 44.2K shares of Teva Pharmaceutical Industries Limited (TEVA) worth $892,738, representing 0.00% of the portfolio. First purchased in 2014-Q2, this long-term strategic position has been held for 46 quarters.
Based on 13F filings since 2013, Cliff Asness has maintained a long-term strategic position in TEVA, representing a significant commitment to this investment thesis. Largest addition occurred in Q3 2014, adding 103.1K shares. Largest reduction occurred in Q2 2024, reducing 190.8K shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Teva Pharmaceutical Industries Limited (TEVA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Teva Pharmaceutical Industries Limited (TEVA) Trades by Cliff Asness
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2014 | +103,811 | New Buy | 103,811 | $52.42 |
| Q3 2014 | +103,108 | Add 99.32% | 206,919 | $53.75 |
| Q1 2015 | -206,919 | Sold Out | 206,919 | $0.00 |
| Q2 2024 | +16,144 | New Buy | 16,144 | $16.25 |
| Q3 2024 | +1,433 | Add 8.88% | 17,577 | $18.02 |
| Q4 2024 | +1,646 | Add 9.36% | 19,223 | $22.04 |
| Q1 2025 | +4,732 | Add 24.62% | 23,955 | $15.37 |
| Q2 2025 | +2,074 | Add 8.66% | 26,029 | $16.76 |
| Q3 2025 | +18,166 | Add 69.79% | 44,195 | $20.20 |
Cliff Asness's Teva Pharmaceutical Industries Limited Investment FAQs
Cliff Asness first purchased Teva Pharmaceutical Industries Limited (TEVA) in Q2 2014, acquiring 103,811 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Teva Pharmaceutical Industries Limited (TEVA) for 46 quarters since Q2 2014. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness's largest addition to Teva Pharmaceutical Industries Limited (TEVA) was in Q2 2014, adding 103,811 shares worth $5.44 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Cliff Asness's firm, Aqr Capital Management LLC, owns 44,195 shares of Teva Pharmaceutical Industries Limited (TEVA), valued at approximately $892,738. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Teva Pharmaceutical Industries Limited (TEVA) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness's peak holding in Teva Pharmaceutical Industries Limited (TEVA) was 206,919 shares, as reported at the end of Q3 2014. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.